In addition, Vav3 is implicated in receptor-triggered angiogenesis (Hunter et al. 2006), and host deficiency in Vav2/Vav3 retards tumor growth based on impaired vascularization within the tumor bed (Brantley-Sieders et al. 2009). Here, VAV2 is linked to neoplasm.